Allogene Therapeutics, Inc.
← Back to ALLO Overview

Allogene Therapeutics, Inc. (ALLO)

Revenue & Top-Line Growth

Latest Revenue

$-

Financial Fundamentals

ALLOQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B0.00B
2025-12-310.00B0.00B
2025-09-300.00B0.00B
2025-06-300.00B0.00B
2025-03-310.00B0.00B
2024-12-310.00B0.00B-26.7%
2024-09-300.00B-0.00B-118.2%
2024-06-300.00B0.00B
2024-03-310.00B-150.0%-26.7%0.00B-89.6%
2023-12-31-0.00B-300.0%-193.6%0.00B-87.7%
2023-09-300.00B0.0%-55.1%0.00B-51.0%
2023-06-300.00B-26.7%-74.4%0.00B-40.1%
2023-03-310.00B-36.2%-50.8%0.00B+3.4%
2022-12-310.00B-4.1%-7.8%0.00B-99.4%
2022-09-300.00B-43.0%0.0%0.00B-99.4%
2022-06-300.00B+41.0%+95.5%0.00B-99.4%
2022-03-310.00B+19.6%-99.8%0.00B-99.5%
2021-12-310.00B+4.1%0.04B
2021-09-300.00B+11.4%0.04B
2021-06-300.00B-99.9%0.04B
2021-03-310.04B0.04B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B
2019-12-310.00B0.00B
2019-09-300.00B0.00B
2019-06-300.00B0.00B
2019-03-310.00B0.00B
2018-12-310.00B0.00B
2018-09-300.00B0.00B
2018-06-300.00B0.00B
2018-03-310.00B0.00B
2017-12-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.00B
20240.00B-76.8%
20230.00B-39.1%
20220.00B-99.9%
20210.11B
20200.00B
20190.00B
20180.00B
20170.00B